To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company is one of a handful ...

This article first appeared on GuruFocus. Scribe Therapeutics (NASDAQ:SCTX), a clinical-stage developer of gene therapies for heart disease, surged 67% on Friday after raising $128.7 million in an ...

Scribe Therapeutics (SCTX), a gene therapy developer whose collaborators include Sanofi (SNY) and Eli Lilly (LLY), rose nearly 50% in its first trading session as a public company on Friday after an ...

Scribe Therapeutics has overshot its own expectations with an IPO that's set to bring in $128.7 million for the in vivo gene editing outfit. Scribe is issuing 8.6 million shares—above the 7.1 million ...

For many people, managing a disease means chronic therapy. Scribe Therapeutics has a different vision: genetic medicines that offer durable effects for the masses. With its lead program on a path to ...

This article first appeared on GuruFocus. Scribe Therapeutics, a clinical-stage developer of gene therapies for heart disease, is seeking to raise as much as $107.2 million through a U.S. initial ...

Scribe Therapeutics Inc. (SCTX) has filed to raise drug development investment in an IPO, according to an S-1 registration statement. The firm is a clinical-stage biopharma developing gene editing ...

Scribe expects to bring in $96.2 million, rising to $110.2 million if underwriters fully exercise their option to buy an additional 1 million shares at the same price. (Grzegorz Zdziarski/iStock/Getty ...

Lizenztyp: Die Software ist als kostenlose Version verfügbar, mit der Möglichkeit, auf eine professionelle Version mit erweiterten Funktionen zu upgraden. Betriebssysteme: Express Scribe ist ...

Andy is a seasoned technology journalist with more than 15 years experience in the mobile industry, writing for Digital Trends, Wired, and more. Andy has reviewed hundreds of smartphones and tablets, ...

The new Kindle Scribe Colorsoft is currently seeing its first discount as part of Amazon's Prime Day sale. For a limited time, you can snag this premium Kindle device for 24% off. The Kindle Scribe ...

Amazon's new Kindle Scribe foregoes the front light for a more affordable $429: pitting it against the ReMarkable Paper Pure. Follow ZDNET: Add us as a preferred source on Google. Amazon’s Kindle ...